Table 2 Pre-treatment clinical information, treatment modality, and follow-up information for 37 patients with morphological evidence of no treatment effect in prostate cancer at salvage radical prostatectomy.

From: Enrichment of “Cribriform” morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer

Clinical, treatment-modality and follow up information

Number (%)

Median age in years

69 (range, 54–78)

Median PSA (ng/ml) at diagnosis

5.15 (range, 3.1–12)

Biopsy grade group

  1

16 (43)

  2

9 (24)

  3

2 (5)

  4

1 (3)

  5

1 (3)

  NA

8 (21)

 Median percent core involvement

33 (range, 5–90)

Type of radiation treatment

  IMRT

12

  Brachytherapy

9

  XRT

3

  Brachytherapy + XRT

2

  Proton therapy

1

  HDR

1

  NA

9

Androgen deprivation therapy

  Yes

13

  No

19

Median time in months from dx to recurrence

6 (range, 1–17)

Median time in months from dx to salvage RP

7 (range, 1–17)

  1. NA not available, RP radical prostatectomy, IMRT intensive modulated radiation therapy, XRT radiation therapy, HDR high dose rate brachytherapy, dx diagnosis.